Host Defense Peptides as Templates for Antifungal Drug Development
Current treatment for invasive fungal diseases is limited to three classes of antifungal drugs: azoles, polyenes, and echinocandins. The most recently introduced antifungal class, the echinocandins, was first approved nearly 30 years ago. The limited antifungal drug portfolio is rapidly losing its c...
Main Authors: | Virginia Basso, Dat Q. Tran, André J. Ouellette, Michael E. Selsted |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-10-01
|
Series: | Journal of Fungi |
Subjects: | |
Online Access: | https://www.mdpi.com/2309-608X/6/4/241 |
Similar Items
-
Defensins: antifungal lessons from eukaryotes
by: Patrícia M. Silva, et al.
Published: (2014-03-01) -
The Network of Colonic Host Defense Peptides as an Innate Immune Defense Against Enteropathogenic Bacteria
by: Graham A. D. Blyth, et al.
Published: (2020-05-01) -
Functions of Cationic Host Defense Peptides in Immunity
by: Mahadevappa Hemshekhar, et al.
Published: (2016-07-01) -
Antimicrobial Peptides in Early-Life Host Defense, Perinatal Infections, and Necrotizing Enterocolitis—An Update
by: Eleni Agakidou, et al.
Published: (2022-08-01) -
Killing of Staphylococci by θ-Defensins Involves Membrane Impairment and Activation of Autolytic Enzymes
by: Miriam Wilmes, et al.
Published: (2014-11-01)